The antioxidant protein peroxiredoxin (Prx) I is a thioredoxin peroxidase that is involved in the regulation of proliferation and differentiation of mammalian cells. Here, it is shown that Prx I gene expression was induced transcriptionally by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) in cultured rat liver tissue macrophages and RAW264.7 monocytic cells. TPA-dependent induction of Prx I gene expression was mediated by two proximal activator protein-1 sites of the rat Prx I promoter region that were nuclear targets of c-Jun as determined by transfection studies with luciferase reporter gene constructs and electrophoretic mobility shift assays. The transcription factor Nrf2, however, was not involved in the regulation of Prx I promoter activity. Prx I gene induction by TPA was decreased by protein kinase C inhibitors and overexpressed dominant negative forms of Ras and MEKK1, but not Raf-1. The p38 MAPK inhibitor SB202190 and overexpression of dominant negative mutants of MAPK kinase 4 (MKK4), MKK6, and p38 inhibited the TPA-dependent induction of Prx I gene transcription. In contrast, inhibitors of the JNK, SP600125, and the NF-B signaling pathway, caffeic acid phenethyl ester, respectively, as well as overexpressed dominant negative MKK7 and IB, had no effect on the up-regulation of Prx I reporter gene activity by TPA. Cotransfection of wild-type p38␣ and p38␤, but not that of p38␥ and p38␦, increased Prx I promoter activity. The data indicate that a protein kinase C, Ras, MEKK1, p38 MAPK signaling pathway plays a major role for the transcriptional up-regulation of Prx I gene expression.
Peroxiredoxin (Prx) 1 I is an intracellular antioxidant protein with thioredoxin peroxidase activity that has initially been purified from human HeLa cells (proliferation-associated gene; see Ref. 1) , mouse peritoneal macrophages (mouse stress protein 23; see Ref. 2) , and rat liver (heme-binding protein 23; see Ref. 3) . Prx I belongs to the Prx protein family and is characterized by conserved cysteine residues (4 -7). Prxs have been identified in numerous organisms ranging from bacteria and plants up to vertebrates and mammals and are divided into three classes: typical two-cysteine Prxs (Prx I-IV), atypical two-cysteine Prxs (Prx V), and one-cysteine Prxs (Prx VI) (8, 9) . The functions of these proteins comprise modulation of signal transduction and cell proliferation, as well as protection against oxidative stress (10 -15) . Therefore, Prxs may complement other enzymes with antioxidant potential such as superoxide dismutase, catalase, or glutathione peroxidase that have been ascribed protective roles in inflammation, cancer, or neurodegenerative disease (16 -18) .
The enzyme activity of Prxs is regulated by post-translational mechanisms such as protein phosphorylation, proteolysis, and oligomerization (9, 19, 20) . More recently, a redox-dependent mechanism for the reversible peroxidase activation of Prx I involving the active site cysteine has been demonstrated by Woo et al. (21) . However, little is known on the mechanisms that regulate gene expression of Prxs in mammalian cells. We and others (22) (23) (24) (25) have shown previously that Prx I gene expression is induced by a number of oxidative stress stimuli including heme, heavy metals, and oxidized low density lipoproteins in various cell culture models. Because Prx I appears to play an important role in carcinogenesis as a tumor suppressor (14, 15 ) the goal of the present study was to investigate the regulation of Prx I gene expression by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA). TPA is a tumor promoter that activates protein kinase C (PKC) (26, 27) , and here it is demonstrated that TPA induces Prx I gene expression in cultured monocytic cells. By transient transfection of reporter gene constructs with the newly cloned 5Ј-flanking promoter region of the Prx I gene it is shown that activator protein-1 (AP-1) sites of the rat Prx I promoter region play a crucial role for the TPA-dependent gene induction via interaction with c-Jun. The induction of Prx I promoter activity is mediated by a signaling pathway involving PKC, Ras, mitogenactivated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) kinase kinase (MEKK) 1, and p38 MAPK isoforms.
EXPERIMENTAL PROCEDURES
Materials-Media M199 and Dulbecco's modified Eagle's medium were obtained from Invitrogen, nitrocellulose filters were from Schleicher & Schuell, and radioisotopes and the ECL chemiluminescent detection system for Western blot were from Amersham Biosciences. The nucleotide removal kit was from Qiagen, and the multiprime labeling kit, restriction endonucleases, and terminal deoxynucleotidyl transferase were from New England Biolabs (Cambridge, MA). Falcon tissue culture dishes were from BD Biosciences. All other chemicals were purchased from Sigma and Roche Applied Science unless otherwise indicated.
Cell Isolation and Culture-Liver tissue macrophages (Kupffer cells) were isolated from livers of male Wistar rats (2 months old, body weight 170 to 200 g) according to Knook and Sleyster (28) as described previously (23) . In brief, the liver was digested with Pronase/collagenase solutions, and non-parenchymal cells were separated by density gradient centrifugation. Liver tissue macrophages were purified by counterflow elutriation (J2-21, JE-B6 rotor; Beckman Instruments, Fullerton, CA), and the obtained liver tissue macrophages were resuspended in medium M199 containing 15% fetal calf serum, 100 units penicillin/ml and 100 g streptomycin/ml. Cell viability was assessed by trypan blue staining. Cells were plated on 6-well plates (3 ϫ 10 6 cells/well) for preparation of RNA or protein. After 2 h cells were washed for elimination of non-adherent cells. RAW264.7 cells were from American Type Culture Collection (Manassas, VA) and were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 100 units penicillin/ml and 100 g streptomycin/ml. Cell cultures were kept under air/CO 2 (19:1) at 100% humidity. Treatment of cells with TPA was performed with serum-free medium.
Western Blot Analysis-After washing of cell cultures twice with FIG. 1. Induction of Prx I gene expression by TPA in cultures of rat liver tissue macrophages and RAW264.7 cells. Rat liver tissue macrophages (Kupffer cells) and RAW264.7 cells were cultured as described under "Experimental Procedures." Cell cultures were kept for 18 h in serum-free medium before treatment with TPA. A, rat liver tissue macrophages (left panel) or RAW264.7 cells (right panel) were cultured for 6 h under control conditions or in the presence of TPA (0.5 M). Total RNA (15 g) was subjected to Northern analysis, and blots were sequentially probed with a 32 P-labeled cDNA for Prx I and a 28 S rRNA oligonucleotide. The size marker was the 18 S rRNA band. B, cultures of rat liver tissue macrophages (left panel) and RAW264.7 cells (right panel) were maintained in the absence or presence of TPA (0.5 M) for 16 h. Total protein (50 g) was subjected to Western blot analysis and probed with a polyclonal antibody against rat Prx I. Autoradiograms from representative experiments are shown in A and B, respectively. C-E, RAW 264.7 cells were cultured in the presence of TPA (0.5 M) for the times indicated (C), for 6 h in the presence of increasing concentrations of TPA (D), or for 30 min with actinomycin D (1 g/ml) before TPA (0.5 M) was added for another 6 h (E). Total RNA (15 g) was subjected to Northern blot analysis as described in A. Autoradiograms were quantitated with a phosphorimager, and the signal of the 28 S rRNA band served as an internal standard. Values Ϯ S.E. represent the -fold induction of Prx I mRNA normalized to 28 S rRNA from at least three independent experiments. Statistics, Student's t test for paired values: *, significant difference TPA versus control; **, actinomycin D ϩ TPA versus TPA, p Յ 0.05. AD, actinomycin D; con, control; LTM, liver tissue macrophages; RAW, RAW264.7 cells.
FIG. 2.
Nucleotide sequence of the rat Prx I gene promoter and potential AP-1 and NF-B sites. Nucleotides are numbered relative to the transcription initiation site (ϩ1), which is demonstrated by an arrow. The translational start site is indicated by ATG in bold. The TATA box and DNA sequences with homology to the AP-1 and NF-B consensus motifs are in bold. AP-1-A, AP-1-B, and AP-1-C sites that were examined in detail are underlined.
0.9% NaCl, total protein was prepared essentially as described (23) . After addition of 1 ml of lysis buffer (0.1% SDS, 10 mM Tris, pH 7.4), cells were boiled for 5 min and homogenized by passing through a 25-gauge needle. The homogenate was centrifuged for 5 min at 4°C, and the protein content was determined in the supernatant using the Bradford method. 50 g of total protein was loaded onto a 12% SDSpolyacrylamide gel and was blotted onto nitrocellulose membranes by electroblotting. Membranes were blocked with Tris-buffered saline con-
FIG. 3.
Identification of functional AP-1 sites in the rat Prx I promoter that mediate TPA-dependent induction. The indicated rat Prx I promoter fragments were cloned either into pGL3-Basic (A) or as enhancers in 5Ј-3Ј or 3Ј-5Ј orientation in front of the SV40 promoter into pGL3-Prom (B). The localization of AP-1-A, AP-1-B, and AP-1-C sites is indicated. The various reporter gene constructs were transiently transfected into cultured RAW264.7 cells. 24 h after transfection cells were treated for 16 h with control medium or medium supplemented with TPA (0.5 M) as indicated. Cell extracts were assayed for luciferase activity, and the -fold induction in each experiment relative to the control was determined. The values are S.E. from four to six independent experiments with duplicates of each point. Statistics, Student's t test for paired values: *, significant difference TPA versus control, p Յ 0.05. C, Prx I promoter luciferase gene constructs with targeted mutations in AP-1-A and AP-1-B sites of pPrx558 were generated as described under "Experimental Procedures," and point mutations in AP-1-A and AP-1-B sites are underlined and in italics. These Prx I reporter gene constructs and a luciferase construct with six copies of the AP-1 consensus motif (pAP-1luc; see Ref. 29) were transiently transfected into cultured RAW264.7 cells. 24 h after transfection cells were treated for 16 h with control medium or medium supplemented with TPA (0.5 M) as indicated. Cell extracts were assayed for luciferase activity, and the -fold induction in each experiment relative to the control was determined. The values are S.E. from four to six independent experiments with duplicates of each point. Statistics, Student's t test for paired values: *, significant differences TPA versus control; **, pPrx558mutA ϩ TPA versus pPrx558 ϩ TPA, pPrx558mutAB ϩ TPA versus pPrx558 ϩ TPA, p Յ 0.05. HSV, herpes simplex virus promoter; Luc, luciferase; SV40, simian virus 40 promoter. taining 1% bovine serum albumin, 10 mM Tris/HCl, pH 7.5, and 0.1% Tween for 1 h at room temperature. The primary polyclonal antibody for Prx I (3) was added at 1:1000 dilution, and the blot was incubated for 12 h at 4°C. The secondary anti-rabbit IgG was diluted 1:8000, and the ECL chemiluminescent detection system was used for detection according to the manufacturer's instructions. The primary antibodies for the detection of phosphorylated and total MAPKs were from Cell Signaling (Beverly, MA) and were applied at the concentrations recommended by the manufacturer.
RNA Isolation, Northern Blot Analysis, and Hybridization-Total RNA for Northern blotting was isolated as described previously (23) . Equal quantities of RNA were separated on 1.2% agarose/2.2 M formaldehyde gels. After electrophoresis, RNA was blotted onto nitrocellulose membranes and baked at 80°C for 4 h. After prehybridization for 4 h at 42°C, blots were hybridized overnight with ␣ [ 32 P]dCTP-radiolabeled cDNA probes at 42°C essentially as described (23) . The hybridization solution contained 6ϫ SSC, 5ϫ Denhardt's solution (0.2% Ficoll 400, 0.2% polyvinylpyrrolidone, and 0.2% bovine serum albumin), 0.5% SDS, 50% formamide, and 100 g/ml denatured salmon sperm DNA. Blots were washed subsequently with 2ϫ SSC/0.1% SDS (once) and 0.1ϫ SSC/0.1% SDS (twice) at 65°C. Filters were autoradiographed with x-ray films (X-OMAT RP; Eastman Kodak Co., Rochester, NY) at Ϫ70°C for up to 48 h or were displayed to a phosphorimager screen for 4 -8 h, and radioactivity was measured with Imagequant software (Molecular Dynamics, Sunnyvale, CA). When nitrocellulose filters were sequentially hybridized with different probes the 32 P-labeled cDNA was removed after autoradiography by two washing steps with boiling 0.05ϫ SSC/0.1% SDS for 15 min before rehybridization.
cDNA Probe-As a probe for hybridization the cDNA of rat Prx I was applied (22) . The cDNA fragment was labeled by the oligomer method with ␣ [ 32 P]dCTP using the multiprime DNA labeling kit according to the manufacturer's instructions. To correct for differences in RNA loading filters were rehybridized with a 28 S ribosomal RNA (rRNA) oligonucleotide, which was labeled with [␥- 32 P]dATP at the 5Ј-end with T4 polynucleotide kinase.
Cloning of the 5Ј-Flanking Region of the Prx I Gene Promoter-The proximal promoter 5Ј-flanking region of the rat Prx I gene was isolated using the Genome Walker TM kit from Clontech (Palo Alto, CA), which contains separate pools (libraries) of uncloned, genomic DNA that have been predigested with EcoRV, ScaI, DraI, PvuII, or SspI and ligated to an oligonucleotide anchor (adapter primer 1). A nested PCR approach was employed. The first PCR was performed with the adapter primer 1 (as described in the kit) and a 25-bp primer from position 55 to 31 of the Prx I cDNA (3) (5Ј-CTTGCTATCAGCAGAGTCGAGCTAC-3Ј) on a DNA cycler (PerkinElmer Life Sciences) using a program of 94°C ϫ 25 s, 72°C ϫ 3 min for seven cycles, 94°C ϫ 25 s, 67°C ϫ 3 min for 32 cycles, and 67°C ϫ 4 min for one cycle. After analysis of an aliquot of the PCR products on a 1% agarose gel, the PCR products were diluted 1:50 in sterile deionized H 2 O and subjected to a second round of PCR. The second PCR was performed with the adapter primer 2 and the nested 26-bp primer from position 31 to 9 of the Prx I cDNA (5Ј-CAGGTCT-CACAAACAGAACCAACCGT-3Ј) using a program of 94°C ϫ 25 s, 72°C ϫ 3 min for five cycles, 94°C ϫ 25 s, 67°C ϫ 3 min for 20 cycles, and 67°C ϫ 4 min for one cycle. The amplified PCR products were separated by electrophoresis, subcloned into the pCR2.1 TM vector (Invitrogen) to generate plasmid pCRPrxProm, and sequenced in both directions.
Plasmid Constructs-A MluI/XhoI fragment from plasmid pCRPrxProm was cloned into promoterless pGL3-Basic plasmid to generate pPrx1750. Deletion mutants pPrx1209, pPrx897, pPrx558, pPrx283, and pPrx127 were generated by PCR using oligonucleotides Prx1209 (5Ј-CATAGCAAAAAGCAAACTTTC-3Ј), Prx897 (5Ј-GTTCTGTCTCAC-TTCCTCG-3Ј), Prx558 (5Ј-AAGAGACTTTTGGGGGACATC-3Ј), Prx283 (5Ј-GCAGGGCCAGGAGAC-3Ј), and Prx127 (5Ј-GACCAGTGAAGCTC-TTTTC-3Ј) as forward primers, respectively, and oligonucleotide Prxbasic (5Ј-TCTGGCACCTGCACTTG-3Ј) as a reverse primer. PCR products were religated by standard procedures. To construct plasmid pPrx897/668 and pPrx668/897 specific primers with adjacent SacI or BglII restriction sites were generated. For pPrx897/668 the forward primer Prx897SacIF (5Ј-AATCGGAGCTCGTTCTGTCTCACTTCCCT-CGC-3Ј) with a SacI restriction site and the reverse primer Prx668Bg-lIIR (5Ј-GACTGAGATCTTGTTTGCTGAACACCATGAC-3Ј) with a BglII restriction site were used for PCR with pPrx1750 as template. After digestion with SacI and BglII the PCR fragment was cloned into
FIG. 3-continued
the SacI/BglII sites of pGL3-Prom. Plasmid pPrx668/897 was constructed accordingly with the forward primer Prx897BglIIF (5Ј-GACT-GAGATCTGTTCTGTCTCACTTCCTCGC-3Ј) and the reverse primer Prx668SacIR (5Ј-AATCGGAGCTCTGTTTGCTGAACACCATGAC-3Ј). In a similar fashion pPrx667/283 and pPrx283/667 were generated by using the primer pairs Prx667SacIF (5Ј-AATCGGAGCTCCCATGGG-GTCGGGTCCCAG-3Ј) and Prx283BglIIR (5Ј-GACTGAGA TCTCCA-CTGTCATCAACAACCAAAG-3Ј) or Prx667BglIIF (5Ј-GACTGAGATC-TCCATG GGGTCGGGTCCCAG-3Ј) and Prx283SacIR (5Ј-AATCGGAG-CTCCCACTGTCATCAA CAACCAAAG-3Ј), respectively. pPrx282/108 and pPrx108/282 were generated by using the primer pairs Prx282SacIF (5Ј-AATCGGAGCTCCAGGGCCAGGAGACCTAATG-3Ј) and Prx108BglIIR (5Ј-GACTGAGATCTGGAAAAGAGCTTCACTG-GTC-3Ј) and Prx282BglIIF (5Ј-GACTGAGATCTCAGGGCCAGGAGAC-CTAATG-3Ј) and Prx108SacIR (5Ј-AATCGGAGCTCGGAAAAGAGCT-TCACTGGTC-3Ј), respectively.
Plasmid pPrx558mutA was generated with the template pPrx558 and the oligonucleotide MutAfor (5Ј-GTCAGACAGGAAGACTGTGTG-TATGGGC-3Ј) as forward primer and the oligonucleotide MutArev (5Ј-AACCCCTGTCTCTGTCATCTCTGTTCC-3Ј) as reverse primer. Plasmid pPrx558mutB was generated with the oligonucleotide MutB2for (5Ј-AGTCAAAAGCTTATTCTAAAGTGCAGGGTC-3Ј) as forward primer and MutB2rev (5Ј-ACGGAGTCATAGTCTCTGTGCTACAGC-3Ј) and pPrx558 as template. To construct plasmid pPrx558mutAB oligonucleotides MutAfor and MutArev were applied for PCR with plasmid pPrx558mutB as template. All PCR fragments were religated by standard procedures, and the constructs were verified by DNA sequencing in both directions. The luciferase reporter gene construct pAP-1luc with six copies of the AP-1 enhancer was a gift from Dr. Brent Carter (University of Iowa College of Medicine, Iowa City, IA) (29) , and pNF-Bluc was purchased from Stratagene. Expression vectors for constitutively active H-Ras (Q61L mutant), dominant negative H-Ras (S17N mutant), constitutively active Raf-1 (Y340D mutant), and dominant negative Raf-1 (K375M mutant) have been described (30) . Expression plasmids for MAPK signaling pathway components were generous gifts: MEKK1 and dominant negative MEKK1 were from Dr. Melanie Cobb (Southwestern Medical Center, Houston, TX), dominant negative MAPK kinase (MKK)6 were from Dr. Sylvio Gutkind (National Institutes of Health, Bethesda, MD), dominant negative MKK4 were from Dr. Ulf Rapp (University of Wü rzburg, Wü rzburg, Germany), dominant negative MKK7 were from Dr. Eisuke Nishida (University of Kyoto, Kyoto, Japan), wild-type and dominant negative mutants (AF) of p38␣, p38␤, p38␥, and p38␦ were from Dr. J. Han (Scripps Research Institute, La Jolla, CA), and dominant negative IB were from Dr. Richard Gaynor (Southwestern Medical Center, Houston, TX). Expression vectors for c-Jun, dominant negative c-Jun, Nrf2 (nuclear factor E2-related factor 2), dominant negative Nrf2, and the p3xStREluc reporter plasmid with three copies of the heme oxygenase-1 antioxidant response element (ARE) were provided by Dr. Jawed Alam (Alton Ochsner Foundation, New Orleans, LA).
Transfection and Luciferase Assay-After growth for 16 h transfection of plasmid DNA into RAW264.7 cells was performed by the liposome method using FuGENE (Roche Applied Science) according to the manufacturer's instructions. Unless otherwise stated cells were transfected with 1 g of reporter plasmid and 0.1 to 0.5 g of cotransfected expression vectors. Equal amounts of DNA were adjusted with the respective empty expression vector. Cells were lysed with 1ϫ luciferase lysis buffer, and luciferase activity was determined with a luciferase assay system (Promega, Madison, WI) according to the manufacturer's instructions. Cells were either harvested 24 h after transfection or and Prx I AP-1-Amut, 5Ј-GACAGGGGTTCTCAGACAGGA-3Ј. The AP-1 consensus oligonucleotide with the sequence 5Ј-CGCTTGAT-GAGTCAGCCGGAA-3Ј was from Promega. Equal amounts of complementary oligonucleotides were annealed and labeled by 5Ј-end labeling with [␥-32 P]dATP and T4 polynucleotide kinase. They were purified with the nucleotide removal kit. Binding reactions were carried out in a total volume of 20 l containing 50 mM KCl, 1 mM MgCl 2 , 1 mM EDTA, 5% glycerol, 10 g of nuclear extract, 250 ng poly(dI-dC), and 5 mM dithioerythritol. For competition analyses an excess of unlabeled oligonucleotides was added. After preincubation for 5 min at room temperature, 1 l of the labeled probe (10 4 cpm) was added, and the incubation was continued for an additional 10 min. For supershift analysis 1 l of the c-JunD (epitope corresponding to DNA binding domain), c-JunN (epitope mapping within the N-terminal domain), cAMP regulatory element (RE) binding protein-1 (24H4B), or SP-1 (PEP2-G) antibody (all obtained from Santa Cruz Biotechnology, Inc., Santa Cruz, CA), as well as a rabbit preimmune serum, were added to the EMSA reaction, which was then incubated at 4°C for 2 h. The electrophoresis was then performed with a 4.5% non-denaturing polyacrylamide gel in TBE buffer (89 mM Tris, 89 mM boric acid, 5 mM EDTA) at 200 V. After electrophoresis the gels were dried and exposed to x-ray films.
RESULTS

TPA-dependent Induction of Prx I Gene Expression in Cultured Rat Liver Tissue Macrophages and RAW264.7 Cells-
Regulation of Prx I gene expression by TPA was examined in cultures of rat liver tissue macrophages and the mouse monocytic cell line RAW264.7. As shown by Northern and Western blot analysis TPA caused a pronounced induction of Prx I mRNA and protein expression, respectively (Fig. 1, A and B) . In RAW264.7 cells Prx I mRNA up-regulation by TPA was timedependent with a peak after 6 h (Fig. 1C) . Moreover, a dosedependent increase of Prx I mRNA expression was observed with a maximum at a concentration of 0.5 M TPA (Fig. 1D) . To probe into the mechanism of TPA-dependent Prx I gene induction RAW264.7 cells were treated with actinomycin D, which inhibits cellular transcription. Induction of Prx I mRNA expression by TPA was blocked by pretreatment with actinomycin D suggesting that Prx I gene induction was regulated on the transcriptional level (Fig. 1E) . The data indicate that Prx I gene expression is induced by TPA in cultured monocytic cells. 
Cloning of the Rat Prx I Gene Promoter and Identification of Potential cis-Acting Elements-
To analyze the molecular mechanisms of TPA-dependent Prx I gene expression in more detail we cloned the promoter and 5Ј-flanking region of the rat Prx I gene. For this purpose a nested PCR approach was employed as detailed under "Experimental Procedures." The obtained 1750-bp DNA fragment was subcloned into pCR2.1, and the sequence was determined by standard sequencing methods and deposited into GenBank TM (accession number AJ457059). The transcriptional start site was determined by primer extension analysis using total RNA from RAW264.7 cell cultures and rat liver (data not shown) and was localized 48 bp upstream of the translational start site (Fig. 2) . Sequence comparison of the cloned rat Prx I promoter with the previously characterized promoter region of the human proliferation-associated gene showed no sequence similarity (3, 31) . A TATA box was identified at position Ϫ62 relative to the transcription start site. Putative cis-acting elements were localized by sequence comparison in the cloned promoter 5Ј-flanking region of the rat Prx I gene. Various candidate cis-acting sequences were identified including, but not limited to, AP-1 and NF-B (Fig. 2) . Interestingly, the extended sequence of the AP-1-A site exhibited high homology to the consensus sequence of the ARE, GGTG-ACNNNGCA, which is a target of the transcription factor (TF) Nrf2. Nrf2 has been shown previously (32) to play an important regulatory role for the stress-dependent induction of Prx I gene expression (32) . At this point the functional significance of the identified DNA elements was unclear.
Functional Role of Proximal AP-1 Sites for the TPA-dependent Induction of Prx I Promoter Activity-The importance of cis-acting elements in the regulation of Prx I gene expression was evaluated by ligating the cloned 5Ј-flanking promoter sequence into the luciferase reporter vector pGL3-Basic to give pPrx1750. To identify REs that mediate TPA-dependent induction of Prx I gene expression RAW264.7 cells were transfected with serially 5Ј-deleted Prx I promoter luciferase reporter gene constructs. Luciferase activity of pPrx1750 was induced by TPA 9-fold, and the strongest TPA-dependent up-regulation of luciferase activity was observed for construct pPrx558 (Fig. 3A) .
To assess the regulatory capacity of putative AP-1 sites in the Prx I promoter 5Ј-flanking region various reporter gene constructs were generated by cloning fragments of the Prx I promoter into plasmid pGL3-Prom in front of the SV40 promoter. DNA sequences with the AP-1-A (Ϫ211 to Ϫ205; TGAC-TAA), AP-1-B (Ϫ505 to Ϫ499; TGACTCA), or AP-1-C (Ϫ829 to Ϫ823; TGAGTCA) sites were ligated in either 5Ј-3Ј or 3Ј-5Ј orientation into this luciferase reporter plasmid, respectively. Regulation of these constructs by TPA was compared with that of pPrx887, which contains the promoter with the AP-1-A-C sites in the wild-type context (Fig. 3B) . The strongest TPA-dependent induction of luciferase activity was observed for con- struct pPrx282/108, which contained the AP-1-A site (Fig. 3B) . TPA-dependent induction of pPrx282/108, however, was markedly lower as compared with that of pPrx887 suggesting that both the AP-1-A and the AP-1-B sites may be functional in a cooperative manner.
The functional role of the AP-1-A and AP-1-B sites was also determined by mutation studies. Induction of luciferase activity of pPrx558mutB by TPA was slightly reduced in comparison with that of wild-type pPrx558 (Fig. 3C) , and a markedly stronger reduction of the TPA-mediated Prx I transcriptional activity was observed for pPrx558mutA and pPrx558mutAB (Fig.  3C) . TPA-dependent regulation of pPrx558 was also compared with that of a luciferase reporter gene construct with six copies of the prototypical AP-1 consensus sequence (pAP-1luc; see Ref. 29) . As demonstrated in Fig. 3C the induction of pPrx558 by TPA was markedly higher in comparison with that of pAP-1luc. Thus, the AP-1-A, and to a minor extent the AP-1-B, sites mediate the induction of Prx I promoter activity by TPA.
Up-regulation of Prx I Promoter Activity by Overexpressed c-Jun but Not Nrf2-AP-1 exists as a dimer of Jun and Fos proteins both belonging to the basic leucine zipper family of
TFs (33) . To investigate the regulatory role of c-Jun for Prx I promoter activity RAW264.7 cells were cotransfected with various Prx I promoter luciferase gene constructs and an expression vector encoding a dominant negative mutant of c-Jun. TPA-dependent induction of Prx I promoter activity was downregulated by dominant negative c-Jun (Fig. 4A) . Moreover, the basal and the TPA-dependent induction of Prx I promoter activity was enhanced by overexpressed wild-type c-Jun (Fig.  4B) . In contrast, the pPrx558mutAB construct with targeted mutations in the AP-1-A and AP-1-B sites was only slightly affected by overexpressed c-Jun (Fig. 4C) The extended DNA sequence of the AP-1-A site exhibits high homology to the ARE consensus motif, which may serve as a nuclear target for the TF Nrf2 (34, 35) . To determine the regulatory potential of Nrf2 for this putative ARE we examined the regulation of Prx I reporter gene constructs by cotransfected expression vectors with either wild-type or dominant negative forms of Nrf2. Overexpression of wild-type Nrf2 had no effect on the basal or the TPA-regulated reporter gene activity of pPrx1750 and pPrx558 (Fig. 5A ) but markedly upregulated luciferase activity of control plasmid p3xStRE (34)
FIG. 7. Inhibition of TPA-dependent induction of Prx I gene expression by the PKC inhibitors BIM and stauro.
A, the indicated Prx I promoter luciferase gene constructs were transiently transfected into cultured RAW264.7 cells. 24 h after transfection cells were treated for 16 h with control medium or medium supplemented with TPA (0.5 M), BIM (0.5 M), stauro (0.02 M), TPA plus BIM, or TPA plus stauro as indicated. Cell extracts were assayed for luciferase activity, and the rate of induction in each experiment relative to the control was determined. The values are S.E. from three independent experiments with duplicates of each point. Statistics, Student's t test for paired values: *, significant differences pPrx1750 ϩ TPA versus pPrx1750 control, pPrx558 ϩ TPA versus pPrx558 control; **, pPrx1750 ϩ TPA ϩ BIM versus pPrx1750 ϩ TPA; pPrx1750 ϩ TPA ϩ stauro versus pPrx1750 ϩ TPA; pPrx558 ϩ TPA ϩ BIM versus pPrx558 ϩ TPA, pPrx558 ϩ TPA ϩ stauro versus pPrx558 ϩ TPA, p Յ 0.05. B, after 18 h in serum-free medium RAW264.7 were treated for 6 h with control medium or medium supplemented with TPA (0.5 M), BIM (0.5 M), stauro (0.02 M), TPA plus BIM, or TPA plus stauro as indicated. Total RNA was isolated and subjected to Northern blot analysis. The blots were probed sequentially with a 32 Plabeled cDNA of rat Prx I and a 28 S rRNA oligonucleotide. Values Ϯ S.E. given represent the -fold induction of Prx I mRNA normalized to 28 S rRNA levels from three independent experiments. Statistics, Student's t test for paired values: *, significant differences TPA versus control; **, TPA ϩ BIM versus TPA, TPA ϩ stauro versus TPA, p Յ 0.05. containing three copies of the ARE (data not shown). In addition, basal or TPA-regulated Prx I promoter activity was not affected by overexpressed dominant negative Nrf2 (Fig. 5B) . From the data it is concluded that Prx I promoter gene activity is up-regulated by c-Jun but not by Nrf2.
Binding of c-Jun to the AP-1-A Site of the Prx I Promoter-
In EMSA studies we examined the binding affinity of nuclear proteins from TPA-treated or untreated RAW264.7 cells to radiolabeled oligonucleotides with the Prx I AP-1-A site or the AP-1 consensus motif (Fig. 6A) . No difference in DNA binding affinity from control or TPA-treated cells was observed for the Prx I AP-1-A oligonucleotide (Fig. 6B) . By contrast, nuclear extracts from TPA-treated cells formed a stronger DNA-protein complex with the AP-1 consensus oligonucleotide as compared with extracts from control cells. The DNA-protein band formed with AP-1-A was completely abolished by a 20-fold molar excess of unlabeled AP-1-A oligonucleotide. By contrast, an excess of an oligonucleotide with a targeted mutation in the AP-1-A site (AP-1-Amut) did not affect the intensity of this band (Fig.  6C, left panel) . Incubation of the binding reaction of the AP-1-A oligonucleotide with an antibody against the N-terminal domain of c-Jun produced a supershifted band. Moreover, addition of an antibody raised against the DNA binding domain of c-Jun attenuated the intensity of the DNA-protein complex (Fig. 6C, right panel) . No obvious alteration of the AP-1-A DNA-protein band was observed with antibodies for the TFs cAMP RE-binding protein or SP-1 (data not shown) suggesting that the AP-1-A site is a nuclear target sequence of c-Jun.
The AP-1-B site conferred a relatively minor TPA response when compared with AP-1-A (Fig. 3) . To compare the DNA binding affinities of these two elements for nuclear proteins, equal amounts of nuclear extracts from RAW264.7 cells were incubated with radiolabeled AP-1-A and AP-1-B oligonucleotides. A markedly stronger DNA-protein complex formed with the AP-1-A oligonucleotide as compared with that of AP-1-B. Moreover, a 10-fold molar excess of cold AP-1-A completely abolished the DNA-protein complex of radiolabeled AP-1-B, whereas a 10-fold molar excess of AP-1-B did not abolish the AP-1-A DNA-protein band (Fig. 6D) .
Attenuation of TPA-dependent Induction of Prx I Gene Expression by PKC Inhibitors-TPA activates PKC by interaction with the regulatory PKC domain (26, 27) . To investigate the signaling pathways that are involved in TPA-dependent induction of Prx I promoter activity we tested the effects of the PKC inhibitors bisindolylmaleimide (BIM) and staurosporine (stauro). Both BIM and stauro strongly reduced TPA-dependent induction of pPrx1750 and pPrx558 luciferase activity (Fig.  7A) . The effect of BIM and stauro was also examined for TPAdependent regulation of the endogenous Prx I gene expression by Northern blot analysis. Both agents inhibited the induction of Prx I mRNA levels by TPA (Fig. 7B) suggesting that the PKC pathway is involved in TPA-dependent regulation of Prx I gene expression.
Role of Ras and MEKK1 for the TPA-dependent Induction of Prx I Promoter Activity-A potential target of PKC signaling is the low molecular weight GTP-binding protein Ras (36) . To investigate the role of Ras for the induction of Prx I gene expression by TPA we examined the regulation of Prx I promoter activity by cotransfected expression vectors for dominant negative and constitutively activated Ras. TPA-dependent induction of pPrx558 reporter gene activity was inhibited by overexpressed dominant negative Ras (Fig. 8A) . Overexpression of constitutively activated Ras increased the reporter gene activity of pPrx558 (Fig. 8B) . We also determined the regulatory role of the Ras effector molecules Raf-1 and MEKK1 on Prx I promoter activity. Overexpression of dominant negative Raf-1 did not inhibit Ras-dependent Prx I induction (Fig. 8, A and B) , whereas overexpression of a dominant negative mutant MEKK1 markedly inhibited Ras-dependent induction of Prx I promoter activity (Fig. 8B) .
Next, we examined the effect of overexpressed wild-type MEKK1, which is highly active when overexpressed. Cotransfected wild-type MEKK1 had a marked stimulatory effect on reporter gene activity of pPrx558, whereas overexpression of constitutive activated Raf-1 only had a minor effect (Fig. 8C) . The data suggest that activation of Ras and MEKK1 is involved in the TPA-dependent induction of Prx I gene expression.
Activation of MAPKs by TPA in RAW264.7 Cells-MEKK1 activates downstream MAPK signaling cascades, specifically the JNK and p38 pathways. To determine the potential role of MAPKs for TPA-mediated Prx I gene activation RAW264.7 cells were treated with 0.5 M TPA for various lengths of time, and cell extracts were analyzed for phosphorylated and total MAPKs by Western blotting. Phosphorylated ERK1 and ERK2 were detected only to a minor degree in untreated cells, and an increase in the levels of these species was readily observed with a maximum after 15 min (Fig. 9) . Phosphorylation of JNK and p38 was also observed for up to 4 h (Fig. 9) . The data indicate that ERK, JNK, and p38 MAPKs are activated by TPA in RAW264.7 cells.
Role of p38 in the Regulation of TPA-dependent Prx I Promoter Induction-MEKK1 activates the JNK signaling pathway through phosphorylation of MKK4 and MKK7. In addition, MEKK1 can stimulate the p38 MAPK through phosphorylation of MKK3 and MKK6 (37) . Activation of MKK4, however, can also stimulate the p38 MAPK activity (37) . To further investigate the signaling pathways downstream of MEKK1 that may be involved in the transcriptional Prx I gene regulation we determined the effects of pharmacological MAPK inhibitors, as well as that of overexpressed dominant negative MKKs, on TPA-dependent Prx I promoter induction. The up-regulation of Prx I promoter activity by TPA was inhibited by pretreatment with the p38 inhibitor SB202190 but not by the JNK inhibitor SP600125 (Fig. 10A) . Overexpressed dominant negative MKK4 inhibited the TPA-dependent induction of Prx I promoter activity, whereas overexpressed dominant negative MKK7, which is a specific activator of JNK, had no effect on Prx I gene FIG. 9 . Activation of MAPKs by TPA in RAW264.7 cells. RAW264.7 cells were cultured as described under "Experimental Procedures." Cell cultures were kept for 18 h in serum-free medium before treatment with TPA (0.5 M) for 0.25, 0.5, 1, 2, and 4 h as indicated. Total protein (50 g) was subjected to Western blot analysis and probed with polyclonal antibodies against various MAPKs. Filters were initially used to detect phosphorylated (phospho) MAPKs and then stripped and probed with antibodies that detect total MAPKs. Similar results were obtained in two-three independent experiments. Autoradiograms from representative experiments are shown, respectively.
reporter gene activity (Fig. 10B) . Overexpression of dominant negative MKK6 markedly inhibited TPA-dependent induction of Prx I promoter activity (Fig. 10B) .
To investigate the role of p38 in the regulation of Prx I gene expression, we examined the effect of overexpressed dominant negative p38␣, ␤, ␥, and ␦ isoforms (AF) on TPA-and MEKK1-dependent induction of Prx I promoter activity. TPA-dependent induction of pPrx558 was inhibited to a different extent by various overexpressed dominant negative p38 isoforms (Fig.  11A) . Similarly, the induction of Prx I promoter activity by MEKK1 was decreased by overexpressed dominant negative p38 isoforms. We also determined the effect of cotransfected wild-type p38 isoforms on the reporter gene activity of pPrx558. Overexpression of p38␣ and p38␤, but not that of p38␥ and p38␦, up-regulated the basal activity of Prx I promoter activity (Fig. 11B) . In contrast, none of these p38 isoforms affected the promoter activity of the pPrx558mutAB reporter gene construct with targeted mutations in the AP-1-A and AP-1-B sites (data not shown). Taken together, the data demonstrate that activation of the p38 MAPK pathway plays a major role for the TPA-dependent activation of Prx I gene expression.
The NF-B Signaling Pathway Is Not Involved in the Regulation of Prx I Promoter Activity-The NF-B signaling pathway has been demonstrated to play a regulatory role for TPAdependent induction of various genes (38 -40) . Because the proximal Prx I promoter region contains a putative NF-B site (Fig. 2) we investigated the potential regulatory role of NF-B signaling by examining the effect of the NF-B inhibitor caffeic acid phenethyl ester (CAPE), as well as that of overexpressed dominant negative IB, on TPA-dependent induction of Prx I promoter activity. Pretreatment of cell cultures with CAPE had no effect on TPA-dependent reporter gene induction of pPrx1750. Moreover, TPA-dependent induction of this construct was not inhibited by overexpressed dominant negative IB (Fig. 12B) . Both CAPE and overexpressed dominant negative IB markedly inhibited the TPA-dependent induction of a control reporter gene construct with five copies of the NF-B site (Fig. 12B) . The data suggest that activation of the NF-B signaling pathway does not play a role for TPA-dependent induction of Prx I promoter activity. (20) , and redoxdependent modification (21) . Here, it is reported that gene expression of Prx I is transcriptionally induced by the phorbol ester TPA, which is known to be a tumor promoter. In cultured rat liver tissue macrophages and RAW264.7 cells expression of the endogenous Prx I gene was induced by TPA in a time-and dose-dependent manner (Fig. 1) . To examine the molecular mechanisms of TPA-dependent Prx I induction we cloned the 5Ј-flanking promoter region of the rat Prx I gene (Fig. 2) , which showed little similarity with the promoter sequence of the human homologue proliferation-associated gene (1, 31) . By deletion and mutation studies two proximal AP-1 sites, AP-1-A and AP-1-B, were demonstrated to mediate the TPA-dependent induction of Prx I promoter activity (Fig. 3) . The AP-1-A site that matches the classical AP-1 consensus sequence (TGA(G/ C)TCA) in 6 of 7 bp conferred a major TPA response to the Prx I promoter as compared with the AP-1-B site that is homologous with the AP-1 consensus sequence (Fig. 6A) . The stronger TPA responsiveness of the AP-1-A site coincided with a higher DNA binding affinity of this element for nuclear proteins from RAW264.7 cells (Fig. 6D ). This may suggest that DNA sequences adjacent to the AP-1-A and AP-1-B sites are involved in the regulation of the TPA-dependent induction of Prx I promoter activity. Such a conclusion is also supported by the finding that a reporter gene construct with the Prx I promoter was more strongly induced by TPA as compared with a luciferase gene construct containing six copies of the AP-1 consensus motif (see Fig. 3C and Ref. 29 ). TPA-dependent gene induction via AP-1 sites has been demonstrated previously for other genes such as the monoamine oxidase B gene in HepG2 hepa- FIG. 11 . Regulation of Prx I promoter activity by overexpressed p38 isoforms. A, RAW264.7 cells were cotransfected with expression vectors for dominant negative mutants of p38␣, p38␤, p38␥, and p38␦, along with luciferase reporter gene construct pPrx558. In control experiments pPrx558 was cotransfected with empty expression vector. 24 h after transfection cells were treated for 16 h with control medium or medium supplemented with TPA (0.5 M). Cell extracts were assayed for luciferase activity, and the -fold induction in each experiment relative to the control was determined. The values are S.E. from three independent experiments with duplicates of each point. Statistics, Student's t test for paired values: *, significant difference of TPA versus control; **, significant differences of p38␣ dn ϩ TPA versus control ϩ TPA, p38␤ dn ϩ TPA versus control ϩ TPA, p38␥ dnϩTPA versus control ϩ TPA, p38␦ dn ϩ TPA versus control ϩ TPA, p Յ 0.05. B, RAW264.7 cells were cotransfected with expression vectors for wild-type p38␣, p38␤, p38␥, and p38␦ and luciferase reporter gene construct pPrx558 or empty expression vector as a control. Cell extracts were assayed for luciferase activity, and the rate of induction in each experiment relative to the control was determined. The values are S.E. from three independent experiments with duplicates of each point. Statistics, Student's t test for paired values: *, significant differences of p38␣ versus control, p38␤ versus control; p Յ 0.05. p38dn, dominant negative p38. toma cells (42) or the involucrin A gene in keratinocyte cultures (43, 44) .
AP-1 sites, also designated TPA-response elements, are nuclear targets for homo-or heterodimers of Jun and Fos (33) . The findings of an inhibition of TPA-dependent induction by overexpressed dominant negative c-Jun (Fig. 5A ) and induction by wild-type c-Jun (Fig. 5B ) strongly suggest that this protein is involved in TPA-dependent induction of Prx I promoter activity. The up-regulation of Prx I promoter activity by c-Jun also correlated with the observation that AP-1-A was a nuclear binding site for c-Jun (Fig. 6) . The extended DNA sequence of the AP-1-A site was homologous in 10 of 12 bp with the consensus motif of the ARE that is a target of the TF Nrf2 (34, 35) . Nrf2 has been shown previously (32) to play a major role for Prx I gene induction, because Prx I gene expression was not up-regulated by the stress stimuli sodium arsenite, cadmium chloride, or menadione in cell cultures from Nrf2(Ϫ/Ϫ) mice.
The present data clearly indicate that the activity of the rat Prx I promoter is not regulated by Nrf2 (Fig. 5) , which could be explained by the fact that other functional AREs may be localized outside of the cloned Prx I promoter sequence.
Signaling Pathways of TPA-dependent Prx I Gene Activation-Attenuation of the TPA-dependent induction of Prx I gene expression by PKC inhibitors (Fig. 7) indicated that this kinase is involved in Prx I gene regulation. This finding is similar to a previous report (25) in which Prx I gene activation by sodium arsenite was mediated by a PKC-dependent mechanism in a murine osteoblast cell line. PKC can either be directly activated by interaction of TPA with the regulatory PKC domain, or, alternatively, TPA can stimulate PKC indirectly via up-regulation of NADPH oxidase-mediated production of reactive oxygen species (26, 27 ). An indirect mechanism of TPA-dependent induction of gene expression has been shown previously (45) for the human manganese superoxide dis- FIG. 12 . Effects of CAPE and overexpressed dominant negative IB on TPA-dependent induction of Prx I promoter activity. A, RAW264.7 cells were transfected with luciferase gene constructs either driven by wild-type 1750 bp of the rat Prx I promoter (pPrx1750) or five copies of NF-B sites (pNFBluc). 24 h after transfection cells were preincubated with CAPE for 30 min (4 g/ml) before adding TPA (0.5 M) for 16 h as indicated. In each experiment the -fold induction of luciferase activity by TPA was determined relative to the control, which was set equal to 1. The values are S.E. from at least three independent experiments with duplicates of each point. Statistics, Student's t test for paired values: *, significant difference of pPrx1750 ϩ TPA versus pPrx1750 control, pPrx1750 ϩ CAPE ϩ TPA versus pPrx1750 ϩ CAPE, pNFBluc ϩ TPA versus pNFBluc control; **, pNFBluc ϩ CAPE ϩ TPA versus pNFBluc TPA; p Յ 0.05. B, cells were cotransfected with either dominant negative IB expression vector or empty expression vector and luciferase gene construct pPrx1750 or pNFBluc as indicated. 24 h after transfection cells were incubated for 16 h with control medium or medium supplemented with TPA (0.5 M). Cell extracts were assayed for luciferase activity, and the rate of induction in each experiment relative to the control was determined. The values are S.E. from three independent experiments with duplicates of each point. Statistics, Student's t test for paired values: *, significant difference of pPrx1750 ϩ TPA versus pPrx1750 control, pPrx1750 ϩ IBdn ϩ TPA versus pPrx1750 ϩ IBdn, pNFBluc ϩ TPA versus pNFBluc control; **, pNFBluc ϩ IBdn ϩ TPA versus pNFBluc TPA; p Յ 0.05. IBdn, dominant negative IB. mutase gene in lung carcinoma cells. An important effector molecule of PKC is the low molecular weight GTP-binding protein Ras (36) , which is involved in the induction of Prx I gene expression by TPA as indicated by experiments with dominant negative and constitutively activated Ras mutants (Fig.  8) . Activation of the NF-B pathway has been shown previously (46, 47) to be involved in TPA-and Ras-dependent signaling but does not seem to play a role for the induction of Prx I promoter activity by TPA in our cell culture model (Fig. 12) . Stimulation of Ras, however, can also activate the Raf-1/MEK/ ERK, MEKK1/MEK4,7/JNK, or MEKK1/MEK3,6/p38 signaling cascades (for a review see Ref. 37 ). The three MAPKs, ERK, JNK, and p38, are phosphorylated by treatment with TPA in RAW264.7 cells (Fig. 9) . Because overexpression of dominant negative Raf-1 had no effect on Ras-dependent induction of Prx I promoter activity, the Raf-1/MEK/ERK signaling pathway appears not to be involved in Prx I gene regulation. Ras-dependent induction of Prx I gene transcription, however, was inhibited by overexpressed dominant negative MEKK1, and, in addition, overexpression of wild-type MEKK1 markedly induced Prx I promoter activity (Fig. 8) . Two major downstream targets of MEKK1 are the JNK and p38 MAPK pathways (37) . Studies with pharmacological inhibitors of MAPKs and with dominant negative forms of MKKs suggested that activation of p38 rather than that of JNK is involved in the induction of Prx I gene expression by TPA (Fig. 10 ). This conclusion was supported by the inhibitory effect of overexpressed dominant negative mutants of various p38 isoforms on TPA-dependent Prx I promoter induction (Fig. 11 ). Similar to a recent report (48) in which AP-1-mediated gene regulation has been shown to be modulated in a highly specific manner by various p38 isoforms in human breast cancer cells, overexpressed p38 isoforms had different regulatory effects on Prx I promoter regulation in RAW264.7 cells (Fig. 11) . The findings of the present study also agree with a previous report (49) demonstrating that TPA-dependent activation of the matrix metalloprotease-9 is mediated via p38 activation in UMSCC and NIH3T3 cells. Interaction of AP-1 with the TF TATA-binding protein may be involved in TPA-dependent gene activation via the p38 signaling pathway as demonstrated recently by Carter et al. (29) .
Physiological Functions of Prx I-Prx I belongs to the typical two-cysteine Prxs (Prx I-IV), which are distinct from the atypical two-cysteine Prx, Prx V, and the one-cysteine Prx, Prx VI (8, 9) . Prx I has thioredoxin-dependent peroxidase activity and adds to the cellular defense mechanisms against oxidative stress (9) . Prxs are involved in the cellular regulation of signal transduction, apoptosis, and proliferation (9) . It has been reported previously that Prxs regulate hydrogen peroxide-mediated signal transduction by growth factors and tumor necrosis factor ␣ in NIH3T3 and A431 cells (11) and that of thyrotropin in FRTL-5 thyroid cells (50) . A developmental difference of bacterial and eukaryotic two-cysteine Prxs may have evolved as to their regulatory role for hydrogen-dependent signaling (21) . Because Prxs are both major target molecules of peroxide, as well as peroxide-degrading enzymes in primary cultures of Leydig cells, Rabilloud et al. (51) have suggested that the ratio of active to inactive Prx enzyme may protect against stressmediated apoptosis. Prx I has also been suggested to be a tumor suppressor by regulating cell proliferation and transformation via direct interaction with the oncogenes c-Abl and c-Myc. Wen and Van Etten (14) have shown that Prx I can directly bind to c-Abl and inhibit its cytostatic properties. Moreover, it has been demonstrated recently (15) that Prx I can affect the regulatory properties of c-Myc by interaction with the Myc Box II domain.
The results of the present study provide novel information on the regulatory mechanisms of Prx I gene expression. Further investigations along this line will help to understand the physiology and pathophysiology of Prx I gene expression in health and disease and may result in specific therapeutic interventions in various diseases such as cancer and inflammation.
